Rethinking Gastric Cancer: H. pylori Eradication, Emerging Therapies, and the Role of AI

This week’s episode explores new evidence on H. pylori eradication and gastric cancer prevention, insights from the LEAP-015 trial, the impact of acromegaly on cancer risk, and the promise of AI in biomarker scoring. Plus, we discuss vonoprazan-based regimens, global HIPEC guidelines, and a rare pediatric gastric cancer case that challenges conventional assumptions.